Index of /sites/default/files

 NameLast modifiedSizeDescription

 Parent Directory   -  
 ninesixtyrobots_logo..>2017-11-16 13:49 2.7K 
 logo.png 2017-11-16 13:49 2.9K 
 zen_classic_logo.png 2017-11-17 06:42 2.9K 
 masthead_bg.jpg 2017-11-16 13:49 5.7K 
 TRIPSCouncilAgendaMa..>2017-11-16 13:54 8.4K 
 11May2015-IP-TPP-cov..>2017-11-16 12:49 9.4K 
 Zoellick_Peterson_16..>2017-11-17 06:42 10K 
 kirk2sanders_page2.png 2017-11-16 13:46 11K 
 job-ip-8.pdf 2017-11-16 13:46 14K 
 NatBioScience-NIH Re..>2017-11-16 13:49 17K 
 ustr-acta-rfc_2010-3..>2017-11-16 13:54 18K 
 bug_only_t_green_oil..>2017-11-16 12:51 18K 
 survey_individual_re..>2017-11-16 13:53 20K 
 ACTA-note-package-EU..>2017-11-16 12:50 20K 
 Wyden ACTA Amendment..>2017-11-17 06:42 20K 
 WHA52.19_e19_revised..>2017-11-17 06:42 21K 
 Wyden TPP Transparen..>2017-11-17 06:42 21K 
 KEI_Special301_2012.odt2017-11-16 13:46 23K 
 W605LDCextension2016..>2017-11-17 06:42 23K 
 TACDresolutionOrphan..>2017-11-16 13:54 23K 
 8361977-correction.pdf 2017-11-16 12:50 24K 
 EB129reformdecision.doc2017-11-16 13:42 25K 
 Fabrazyme_Press_Rele..>2017-11-16 13:42 26K 
 Item13.14_AdvanceDra..>2017-11-16 13:46 26K 
 MANON2(2).jpg 2017-11-16 13:49 26K 
 tviflyer.doc 2017-11-16 13:54 26K 
 International_medici..>2017-11-16 13:45 26K 
 brazil_tax_proposal.pdf2017-11-16 12:51 27K 
 WHA66.22_CEWG.pdf 2017-11-17 06:42 27K 
 1206ftcwirelesscom.pdf 2017-11-16 12:49 27K 
 TRIPSCouncilAgendaFe..>2017-11-16 13:54 28K 
 WTOTRIPSCouncilNovem..>2017-11-17 06:42 28K 
 AFUB_REPLY.doc 2017-11-16 12:51 29K 
 TRIPSCouncilOct2011.doc2017-11-16 13:54 29K 
 UStext.doc 2017-11-16 13:54 29K 
 fabrazyme_cover_2aug..>2017-11-16 13:42 29K 
 perkins_reply.doc 2017-11-16 13:49 30K 
 WHO ReformGOVERNANCE..>2017-11-17 06:42 30K 
 jstiglitzTPP.pdf 2017-11-16 13:46 30K 
 130103googlemotorola..>2017-11-16 12:49 30K 
 1989-2004_special301..>2017-11-16 12:50 31K 
 asset_upload_file110..>2017-11-16 12:51 31K 
 SCCR29SummaryofChair..>2017-11-16 13:53 32K 
 survey_individual_re..>2017-11-16 13:53 32K 
 national_medicine_pr..>2017-11-16 13:49 32K 
 response_to_US Govt.doc2017-11-16 13:53 33K 
 Staff_Memo_03_20_198..>2017-11-16 13:53 33K 
 Shionogi-infringemen..>2017-11-16 13:53 34K 
 ifpma-ewg-internal-m..>2017-11-16 13:45 34K 
 PR2_7dec2010_Fabrazy..>2017-11-16 13:50 35K 
 george_kerscher_dais..>2017-11-16 13:42 35K 
 sec84.doc 2017-11-16 13:53 35K 
 NIH2Black_3dec2010.pdf 2017-11-16 13:49 35K 
 james_love_reply.doc 2017-11-16 13:46 35K 
 LDCtransitiondecisio..>2017-11-16 13:49 36K 
 RWA_Letter_8Feb2012-..>2017-11-16 13:53 36K 
 CEWGconflictofintere..>2017-11-16 13:24 36K 
 Consumer_Reply.doc 2017-11-16 13:24 37K 
 PreambleArticles_Nov..>2017-11-16 13:50 37K 
 Articles_E_F_G_and_J..>2017-11-16 12:51 38K 
 KEIstatement_Unlocki..>2017-11-16 13:46 38K 
 WorldHealthForumconc..>2017-11-17 06:42 38K 
 Rights-6-29-15.pdf 2017-11-16 13:53 38K 
 Rights-6-29-15_0.pdf 2017-11-16 13:53 38K 
 AfricaGrouprecommend..>2017-11-16 12:51 39K 
 price_35mg_Fabrazym_..>2017-11-16 13:50 40K 
 Preamble_Nov 19.doc 2017-11-16 13:50 41K 
 text_distributed_fri..>2017-11-16 13:54 41K 
 USTR_20April2011_FOI..>2017-11-16 13:54 41K 
 Google.doc 2017-11-16 13:42 41K 
 WTO TRIPs Council it..>2017-11-17 06:42 42K 
 17-oct-2016-civil-so..>2017-11-16 12:49 42K 
 Global_Competition_N..>2017-11-16 13:42 42K 
 TPP-2012-Nov-29_Toom..>2017-11-16 13:54 42K 
 SCCR-Workplan_new.doc 2017-11-16 13:53 43K 
 Object-of-Protection..>2017-11-16 13:49 43K 
 II. Stakeholder Tabl..>2017-11-16 13:45 43K 
 USTR_11sep2011_TPP_T..>2017-11-16 13:54 43K 
 cover-note-EP-inform..>2017-11-16 13:24 43K 
 BrazilDoha+10.doc 2017-11-16 12:51 44K 
 C-IP_28usc1498.pdf 2017-11-16 13:24 44K 
 FOIA-TPP-Chapter-Nam..>2017-11-16 13:42 44K 
 NIH-Response-31July2..>2017-11-16 13:49 44K 
 lindadempsey.png.pdf 2017-11-16 13:49 44K 
 SenWyden-IndiaIPR-30..>2017-11-16 13:53 45K 
 AdlerDelfs_AAPPositi..>2017-11-16 12:51 45K 
 duloxetine_cymbalta.xls2017-11-16 13:26 45K 
 1914_Berne_Additiona..>2017-11-16 12:49 46K 
 Table_10_IP_Report_M..>2017-11-16 13:54 46K 
 Data_All_summary_130..>2017-11-16 13:25 47K 
 Letter-USTR-FOIA-GE-..>2017-11-16 13:49 47K 
 35-usc-204-waiver-fo..>2017-11-16 12:50 48K 
 Amicus_Holman_AMPvUS..>2017-11-16 12:51 48K 
 S1138_112th.pdf 2017-11-16 13:53 48K 
 Draft_conclusions_11..>2017-11-16 13:26 48K 
 tadalafil_cialis.xls 2017-11-16 13:54 48K 
 nih2amber_britton_22..>2017-11-16 13:49 48K 
 Draft_Conclusions_SC..>2017-11-16 13:26 49K 
 COL196_ES_4.doc 2017-11-16 13:24 51K 
 DOSCable_Brazil_1987..>2017-11-16 13:25 51K 
 WHOReformEVALUATION.pdf2017-11-17 06:42 51K 
 Conclusions_SCCR25_F..>2017-11-16 13:24 51K 
 WBU_REPLY.doc 2017-11-17 06:42 51K 
 sccr_convergence_ES.doc2017-11-16 13:53 52K 
 10mar10_foia_ustr.pdf 2017-11-16 12:49 52K 
 NinaslettertoPhilipB..>2017-11-16 13:49 52K 
 sccr9-7-quotations_r..>2017-11-16 13:53 52K 
 McKinseyconflictofin..>2017-11-16 13:49 52K 
 Ukrainecomplaintobac..>2017-11-16 13:54 53K 
 Ukrainecomplaintobac..>2017-11-16 13:54 53K 
 sccr_convergence_FR.doc2017-11-16 13:53 53K 
 1896_additional_acts..>2017-11-16 12:49 53K 
 S1137_112th.pdf 2017-11-16 13:53 54K 
 jamie_17may2011_scp1..>2017-11-16 13:46 54K 
 TPP-2012-April-4_Res..>2017-11-16 13:54 54K 
 benetech_reply.pdf 2017-11-16 12:51 55K 
 Draft_conclusions_11..>2017-11-16 13:26 55K 
 Sony-DECE-CP1-ss.doc..>2017-11-16 13:53 55K 
 Innovative-elements-..>2017-11-16 13:45 56K 
 Timetable.pdf 2017-11-16 13:54 56K 
 AWP_ART_27March2012.pdf2017-11-16 12:51 56K 
 SCCR_Conclusions_Jul..>2017-11-16 13:53 57K 
 TPP-2011-Dec-6_Repon..>2017-11-16 13:54 57K 
 kirk2sanders_page1.png 2017-11-16 13:46 57K 
 ER_Robert_Weissman_W..>2017-11-16 13:42 57K 
 1886_Berne_Conventio..>2017-11-16 12:49 58K 
 Conclusions_SCCR_21.doc2017-11-16 13:24 58K 
 WIPOAustraliaMOU.pdf 2017-11-17 06:42 58K 
 TPP-2012-June-15_Res..>2017-11-16 13:54 58K 
 ACTA_Round 10 _propo..>2017-11-16 12:51 58K 
 TPP-2011-Dec-6_Respo..>2017-11-16 13:54 59K 
 Number_of_Countries_..>2017-11-16 13:49 60K 
 1908_Berne_Conventio..>2017-11-16 12:49 60K 
 TPP-2012-Oct-5_Respo..>2017-11-16 13:54 60K 
 TPP-2013-Mar-14_Repo..>2017-11-16 13:54 60K 
 IFPMA_analysis_of_EW..>2017-11-16 13:45 60K 
 ifpma-ewg-overview-c..>2017-11-16 13:45 60K 
 Letter_SenatorsOA070..>2017-11-16 13:49 60K 
 Tedmund_wan_survey_n..>2017-11-16 13:54 61K 
 Tedmund_wan_survey_n..>2017-11-16 13:54 61K 
 USPointsonE&LforEduc..>2017-11-16 13:54 61K 
 kei-intervention-13...>2017-11-16 13:46 61K 
 kei-intervention-13...>2017-11-16 13:46 62K 
 Missionbriefingsumma..>2017-11-16 13:49 62K 
 ep-prizes-jamie-18no..>2017-11-16 13:42 62K 
 TPP-2012-July-6_Resp..>2017-11-16 13:54 62K 
 SCCR 19 US Intrvntn ..>2017-11-16 13:53 62K 
 TPP-2013-Mar-14_Resp..>2017-11-16 13:54 62K 
 james_love_kei_13nov..>2017-11-16 13:46 62K 
 TPP-2012-Sept-10_Inh..>2017-11-16 13:54 63K 
 EUTRIPSCouncilMarch2..>2017-11-16 13:42 63K 
 TPP-2012-Oct-5_Respo..>2017-11-16 13:54 63K 
 Ress_Reply_final2.doc 2017-11-16 13:53 63K 
 USPTO_humanitarianli..>2017-11-16 13:54 63K 
 1928_Rome_revisions_..>2017-11-16 12:49 64K 
 03-13-2017-hhs-oig-s..>2017-11-16 12:49 64K 
 TPP-2012-Dec-19_Resp..>2017-11-16 13:54 64K 
 Draft_Feb_20_clean.doc 2017-11-16 13:26 64K 
 HHS-to-Rep-Doggett-0..>2017-11-16 13:42 64K 
 sccr_24_10_corr.pdf 2017-11-16 13:53 64K 
 FOIA_42737_Packet 5_..>2017-11-16 13:42 65K 
 EGAletterMEPSACTA201..>2017-11-16 13:42 65K 
 USWTOTRIPSCouncilJun..>2017-11-16 13:54 65K 
 2012-FOIA-USTR-KEI-C..>2017-11-16 12:50 65K 
 10.20.15_Letter_to_U..>2017-11-16 12:49 65K 
 ustr_foia_acta_trans..>2017-11-16 13:54 65K 
 Cameron_Forbes_Kerry..>2017-11-16 13:24 65K 
 ER_Robert_Weissman_E..>2017-11-16 13:42 66K 
 ethical pathway act ..>2017-11-16 13:42 66K 
 Humalog_insulin_lisp..>2017-11-16 13:42 67K 
 EU_Confidentiality_T..>2017-11-16 13:42 67K 
 ec_letter_mysql_oct1..>2017-11-16 13:42 67K 
 Greece_a2m_31May2013..>2017-11-16 13:42 67K 
 Leahy_TPPA_transpare..>2017-11-16 13:49 68K 
 W619-01.pdf 2017-11-17 06:42 68K 
 bayh_dole_foia_dod.pdf 2017-11-16 12:51 70K 
 bayh_dole_foia_doc.pdf 2017-11-16 12:51 70K 
 bayh_dole_foia_nih.pdf 2017-11-16 12:51 70K 
 bayh_dole_foia_dhhs.pdf2017-11-16 12:51 70K 
 DHHSListeningSession..>2017-11-16 13:25 70K 
 bayh_dole_foia_cdc.pdf 2017-11-16 12:51 70K 
 bayh_dole_foia_fda.pdf 2017-11-16 12:51 71K 
 bayh_dole_foia_da.pdf 2017-11-16 12:51 71K 
 bayh_dole_foia_nsf.pdf 2017-11-16 12:51 71K 
 bayh_dole_foia_nist.pdf2017-11-16 12:51 71K 
 sccr_23_conclusions_..>2017-11-16 13:53 71K 
 part6a2k2005draft.pdf 2017-11-16 13:49 72K 
 ACB and AFB internat..>2017-11-16 12:50 73K 
 bayh_dole_foia_nasa.pdf2017-11-16 12:51 73K 
 CONCLUSIONS SCCR 19[..>2017-11-16 13:24 73K 
 CDC_17feb2015_FOIA_C..>2017-11-16 13:24 74K 
 Hepatitis_UNITAID_30..>2017-11-16 13:42 74K 
 KEI-TradeRelatedAspe..>2017-11-16 13:46 74K 
 2012_Oct25_coverlett..>2017-11-16 12:50 75K 
 Patents with US Gove..>2017-11-16 13:49 75K 
 1948_revision_BerneC..>2017-11-16 12:49 75K 
 pres_martin-prat.doc 2017-11-16 13:50 76K 
 OCR-2015_06_09_14_10..>2017-11-16 13:49 76K 
 TPP-2012-Aug-6_McCas..>2017-11-16 13:54 76K 
 Thaddeus_Burns_GE_Be..>2017-11-16 13:54 76K 
 April20FinalText.doc 2017-11-16 12:51 77K 
 cewg3_open_session.ppt 2017-11-16 13:24 77K 
 SCP26-Flyer-KEIsidee..>2017-11-16 13:53 77K 
 new_treaty_disabilit..>2017-11-16 13:49 77K 
 Definitions-6-29-15.pdf2017-11-16 13:25 77K 
 TPP-2012-July-13_Mar..>2017-11-16 13:54 77K 
 NIH-Response-10July2..>2017-11-16 13:49 78K 
 JointLetterCEWGJanua..>2017-11-16 13:46 78K 
 demarche_OCR_26March..>2017-11-16 13:25 78K 
 ustr_special301_2002..>2017-11-16 13:54 79K 
 TPP-2012-July-6_Resp..>2017-11-16 13:54 79K 
 KEI_Comments_HHS_lis..>2017-11-16 13:46 79K 
 WHO_COI_DOI_Form_fin..>2017-11-17 06:42 80K 
 ER_Robert_Weissman_H..>2017-11-16 13:42 80K 
 KEI_TPP_USTR_Survey_..>2017-11-16 13:46 80K 
 benetech_comments_fo..>2017-11-16 12:51 80K 
 ustr-concurrence-arm..>2017-11-16 13:54 80K 
 Section-F-Industrial..>2017-11-16 13:53 80K 
 TPP-2012-Sept-19_Res..>2017-11-16 13:54 80K 
 Consolidated_version..>2017-11-16 13:24 81K 
 whatswrong-whatcanbe..>2017-11-17 06:42 81K 
 US_paper_on_general_..>2017-11-16 13:54 81K 
 UStext.pdf 2017-11-16 13:54 81K 
 21st-century-cures-g..>2017-11-16 12:50 81K 
 ParticipantList_2012..>2017-11-16 13:49 81K 
 original.jpg 2017-11-16 13:49 81K 
 Chile_24.11.2011_(2...>2017-11-16 13:24 82K 
 AB-463-Assembly-Heal..>2017-11-16 12:50 82K 
 Letter to Army Secre..>2017-11-16 13:49 82K 
 ec-de-tamiflu.pdf 2017-11-16 13:42 83K 
 2july10_foia_ustr.pdf 2017-11-16 12:50 83K 
 sccr_25_consolidated..>2017-11-16 13:53 83K 
 TPP-2012-Sept-19_Rep..>2017-11-16 13:54 84K 
 acta_04-11-2010_1.doc 2017-11-16 12:50 84K 
 acta_04-11-2010_1Int..>2017-11-16 12:50 84K 
 acta_04-11-2010_1_0.doc2017-11-16 12:50 84K 
 Letter_to_Mexican_Go..>2017-11-16 13:49 85K 
 NCAPIP_AB 463 David ..>2017-11-16 13:49 85K 
 thomas_vinje_KEI_sid..>2017-11-16 13:54 85K 
 jamie_scp14sidevent.pdf2017-11-16 13:46 85K 
 Francoise_Castex_Fre..>2017-11-16 13:42 85K 
 IP Watch-3-19-13-Res..>2017-11-16 13:45 86K 
 IPWatch-6-19-13-Resp..>2017-11-16 13:46 86K 
 Froman_ITC_3Aug2013.PDF2017-11-16 13:42 86K 
 USTR_ITC_Apple_Samsu..>2017-11-16 13:54 86K 
 Draft_Feb_18_clean_c..>2017-11-16 13:26 86K 
 TPP_copyrighttermlet..>2017-11-16 13:54 86K 
 ER_Eleanor_Fox_NYU_E..>2017-11-16 13:42 86K 
 A66_DIV3-en.pdf 2017-11-16 12:50 87K 
 Consolidated_Version..>2017-11-16 13:24 87K 
 NIH-responsie-2KEI-m..>2017-11-16 13:49 88K 
 NGO letteronConflict..>2017-11-16 13:49 88K 
 KEIMarrakeshflyer.pdf 2017-11-16 13:46 88K 
 CRISPR_CAR-T_worksho..>2017-11-16 13:24 88K 
 Carta_al_Gobierno_de..>2017-11-16 13:24 88K 
 Workingdocument_VIP.doc2017-11-17 06:42 88K 
 Consolidated_Version..>2017-11-16 13:24 89K 
 Consolidated_Version..>2017-11-16 13:24 89K 
 ER_James_Love_Thiru_..>2017-11-16 13:42 89K 
 Intersessionalworkin..>2017-11-16 13:45 89K 
 ACTA_TEXT_3December2..>2017-11-16 12:51 90K 
 2july10_foia_commerc..>2017-11-16 12:50 90K 
 9nov09_acta_kei_pk_l..>2017-11-16 12:50 90K 
 gr239en.pdf 2017-11-16 13:42 91K 
 PhrMA_2003_Appendix_..>2017-11-16 13:49 92K 
 Intersessionalworkin..>2017-11-16 13:45 94K 
 wipo_is_vip_ppd_ge_1..>2017-11-17 06:42 94K 
 KEI-NAFTA-renegotiat..>2017-11-16 13:46 94K 
 drahos_2002devcountr..>2017-11-16 13:26 94K 
 Annex_D_Mayo_Study_T..>2017-11-16 12:51 94K 
 Annex_D_Mayo_Study_T..>2017-11-16 12:51 94K 
 NGO-xtandi-support-l..>2017-11-16 13:49 94K 
 kei_letter2ep_2010_O..>2017-11-16 13:46 94K 
 Consolidated_Version..>2017-11-16 13:24 95K 
 Feb 21_Rev.doc 2017-11-16 13:42 95K 
 Intersessionalworkin..>2017-11-16 13:45 95K 
 KEI-Part-3-of-3-Comm..>2017-11-16 13:46 95K 
 Non_paper_on_Institu..>2017-11-16 13:49 95K 
 Amicus_AARP_AMPvUSPT..>2017-11-16 12:51 95K 
 AMSA Letter on AB463..>2017-11-16 12:51 95K 
 PhRMA_Industry_Profi..>2017-11-16 13:49 96K 
 ER_James_Love_Thiru_..>2017-11-16 13:42 96K 
 Draft_proposal_on pe..>2017-11-16 13:26 97K 
 24Feb2017-CL-Agenda(..>2017-11-16 12:50 97K 
 KEI_Special301_2012.pdf2017-11-16 13:46 97K 
 KEI-FDA-Hatch-Waxman..>2017-11-16 13:46 97K 
 jamie_13may2010_DSC_..>2017-11-16 13:46 97K 
 1971_revision_of_Ber..>2017-11-16 12:50 97K 
 TheBerneConvention_1..>2017-11-16 13:54 98K 
 W385R1NVS2015WTO.pdf 2017-11-17 06:42 98K 
 EssentialInvetions_S..>2017-11-16 13:42 98K 
 Annex_C_NME_Oncology..>2017-11-16 12:51 98K 
 Annex_C_NME_Oncology..>2017-11-16 12:51 98K 
 KEI_UN_HLM_AIDS_pane..>2017-11-16 13:46 98K 
 06-RCEP-TNC6-WGIP3-I..>2017-11-16 12:49 98K 
 KEIMarrakeshflyer_0.pdf2017-11-16 13:46 99K 
 Sugar.CA_.WHONutriti..>2017-11-16 13:53 99K 
 USCO.March 10-11, 20..>2017-11-16 13:54 101K 
 TPP-2011-September-1..>2017-11-16 13:54 101K 
 BMGF v Teachscape.pdf 2017-11-16 12:51 101K 
 AFTI-2017-Special-30..>2017-11-16 12:51 101K 
 loc_12june2008memo.pdf 2017-11-16 13:49 102K 
 State Dept FOIA Requ..>2017-11-16 13:53 102K 
 15-House-Dems-Colomb..>2017-11-16 12:49 102K 
 FinalMay2013NGOlette..>2017-11-16 13:42 102K 
 India FDA FOIA Reque..>2017-11-16 13:45 102K 
 DHHSListeningSession..>2017-11-16 13:25 102K 
 thailand_cl_foia.pdf 2017-11-16 13:54 103K 
 PHRMA_2005-03-17_114..>2017-11-16 13:49 103K 
 TPP-2012-May-3_Carpe..>2017-11-16 13:54 103K 
 Salubris-8Aug2017.pdf 2017-11-16 13:53 103K 
 ER_Mike_Palmedo_ARV_..>2017-11-16 13:42 103K 
 uspto_humanitarian_p..>2017-11-16 13:54 103K 
 hr3590_amend2858.pdf 2017-11-16 13:42 104K 
 CAP-Doggett-Keynote-..>2017-11-16 13:24 105K 
 KEI-letter-OSTP-03-0..>2017-11-16 13:46 105K 
 trum-drug-pricing-eo..>2017-11-16 13:54 105K 
 Delinkage_Agenda_2De..>2017-11-16 13:25 106K 
 KEI_SCP_response_28F..>2017-11-16 13:46 106K 
 CONCEPT NOTE (Englis..>2017-11-16 13:24 106K 
 2013_Special301Comme..>2017-11-16 12:50 106K 
 noel_wipo_unesco_85_..>2017-11-16 13:49 107K 
 AfricaIPForumDraftAg..>2017-11-16 12:51 108K 
 Letter to USTR on LD..>2017-11-16 13:49 108K 
 MN1_Disabilities_cov..>2017-11-16 13:49 108K 
 MN2Definitionofawork..>2017-11-16 13:49 108K 
 TPP-2011-Sept-8_Lewi..>2017-11-16 13:54 108K 
 Joint_QA_final_2014.pdf2017-11-16 13:46 108K 
 WHA-letter-on-delink..>2017-11-17 06:42 108K 
 Zika-Vaccine-Appeal-..>2017-11-17 06:42 108K 
 ustr_special301_1998..>2017-11-16 13:54 109K 
 KEI-MPP-HCV-28August..>2017-11-16 13:46 109K 
 YP-CDNAB463SupportLe..>2017-11-17 06:42 109K 
 ER_Sandra_Fredman_Ox..>2017-11-16 13:42 110K 
 RFC_1109.pdf 2017-11-16 13:53 110K 
 kei_ewg_comments_090..>2017-11-16 13:46 110K 
 KEI_amicus_Oil_State..>2017-11-16 13:46 110K 
 Amicus_NYIPLA_AMPvUS..>2017-11-16 12:51 111K 
 ER_Sean_Flynn_Exclus..>2017-11-16 13:42 111K 
 RCEP-TNC6-WGIP3-ASEA..>2017-11-16 13:53 111K 
 KEIresponse_TPPAMexi..>2017-11-16 13:46 111K 
 Facilitators Rev 1-1..>2017-11-16 13:42 112K 
 Federal_register_TPP..>2017-11-16 13:42 112K 
 cost_study_backgroun..>2017-11-16 13:24 112K 
 Rishab_Ghosh_Delinka..>2017-11-16 13:53 113K 
 Jrius_GinsburgBesek_..>2017-11-16 13:46 114K 
 1967_Stockholm_Act_r..>2017-11-16 12:50 114K 
 kappos_sanders_brown..>2017-11-16 13:46 114K 
 Amicus_EliLilly_AMPv..>2017-11-16 12:51 114K 
 new_treaty_printer.pdf 2017-11-16 13:49 114K 
 some_background_hiv_..>2017-11-16 13:53 115K 
 HB0631_withHouseAmen..>2017-11-16 13:42 115K 
 Trade_and_Advocacy_B..>2017-11-16 13:54 115K 
 KEI-9Dec2016-Bayh-Do..>2017-11-16 13:46 115K 
 amsa_kei_pc_pirg_uae..>2017-11-16 12:51 116K 
 ifpma-ewg-final-repo..>2017-11-16 13:45 117K 
 ER_Shubha_Ghosh_SUNY..>2017-11-16 13:42 117K 
 eu_15April2011.pdf 2017-11-16 13:42 118K 
 barnier2pescod_2marc..>2017-11-16 12:51 118K 
 Chairs_Nonpaper_7-23..>2017-11-16 13:24 118K 
 EU_comments_on_Borde..>2017-11-16 13:42 118K 
 KEI-NIH-VeriLuce-22J..>2017-11-16 13:46 118K 
 08-1423_doj_costco_a..>2017-11-16 12:49 118K 
 WIPOOpenCollaborativ..>2017-11-17 06:42 119K 
 kei-rn-2014-3.pdf 2017-11-16 13:46 119K 
 USPTO_diagnostics_KE..>2017-11-16 13:54 120K 
 RogerBateletter.pdf 2017-11-16 13:53 121K 
 kirk_lcd_29July2011.pdf2017-11-16 13:46 121K 
 IPCETAchapter.pdf 2017-11-16 13:46 121K 
 Section-B-Cooperatio..>2017-11-16 13:53 124K 
 sccr9-7-quotations_r..>2017-11-16 13:53 124K 
 EU_Comments_on_Civil..>2017-11-16 13:42 125K 
 xtandi-sign-on-lette..>2017-11-17 06:42 125K 
 Summary_of_Comments_..>2017-11-16 13:53 125K 
 WF_316058_March-In_R..>2017-11-17 06:42 126K 
 PublicGoods_WTO.pdf 2017-11-16 13:50 126K 
 StrategyforAmericanI..>2017-11-16 13:53 126K 
 Facilitators Rev. 1-..>2017-11-16 13:42 127K 
 KeyFabryDatesforFTCm..>2017-11-16 13:46 127K 
 TPP-2013-March-22_Ba..>2017-11-16 13:54 128K 
 wto7_kei_public_good..>2017-11-17 06:42 128K 
 NAFTA-Hearing-June27..>2017-11-16 13:49 128K 
 TPP-2012-May-11_Mene..>2017-11-16 13:54 128K 
 PHRMA_Industry_Profi..>2017-11-16 13:49 129K 
 HRC RES 32-15.pdf 2017-11-16 13:42 129K 
 Workingdocument_VIP.pdf2017-11-17 06:42 129K 
 ER_William_Jack_Geor..>2017-11-16 13:42 131K 
 KEI-Response2Sanofi-..>2017-11-16 13:46 131K 
 KEI-USTR-301-submiss..>2017-11-16 13:46 131K 
 brief-astm-v-pub-res..>2017-11-16 12:51 132K 
 DHHSListeningSession..>2017-11-16 13:25 132K 
 Berlin_WTO_PublicGoo..>2017-11-16 12:51 132K 
 Chamber_GIPC_19April..>2017-11-16 13:24 133K 
 delinkage_brussels_1..>2017-11-16 13:25 134K 
 KEI_comments_Draft_C..>2017-11-16 13:46 134K 
 aff-jameslove_13Feb2..>2017-11-16 12:51 136K 
 ustr_special301_2004..>2017-11-16 13:54 136K 
 TTIP_Confidentiality..>2017-11-16 13:54 137K 
 USPTO_Submission.pdf 2017-11-16 13:54 137K 
 ChallengesFacingProp..>2017-11-16 13:24 137K 
 AbPro-A-301-2017_Res..>2017-11-16 12:50 138K 
 2010-08-05_Herrling.pdf2017-11-16 12:50 138K 
 SixMOConTPPa2m_9dec2..>2017-11-16 13:53 139K 
 treaties-trade-agree..>2017-11-16 13:54 139K 
 Amicus_BIO_AMPvUSPTO..>2017-11-16 12:51 140K 
 Letter2Government_of..>2017-11-16 13:49 140K 
 ER_Brook_Baker_Essen..>2017-11-16 13:42 141K 
 Zika-12Jan2016-KEI-A..>2017-11-17 06:42 141K 
 Amicus_james_d__wats..>2017-11-16 12:51 141K 
 KEIsubmission_cewg_6..>2017-11-16 13:46 141K 
 SenWydenRequestLegal..>2017-11-16 13:53 142K 
 Transparency_TAM1222..>2017-11-16 13:54 143K 
 Duke-TPP--ITPlab-OST..>2017-11-16 13:26 143K 
 pl_98-620_chronology..>2017-11-16 13:50 143K 
 Carta_al_Gobierno_de..>2017-11-16 13:24 143K 
 KEI-request-for-info..>2017-11-16 13:46 143K 
 UnitedStates_Amicus_..>2017-11-16 13:54 144K 
 RECP-IP-Chapter-2014..>2017-11-16 13:53 144K 
 Amicus_Kane_AMPvUSPT..>2017-11-16 12:51 144K 
 Annex1Glossary.pdf 2017-11-16 12:51 144K 
 KEI-MSF-Army-Zika-Va..>2017-11-16 13:46 144K 
 KEI-MSF-Letter-to-Ar..>2017-11-16 13:46 144K 
 Nanobernetics-NIH-5S..>2017-11-16 13:49 146K 
 04-26-2016-foia-lett..>2017-11-16 12:49 146K 
 Ress_Reply_final2.pdf 2017-11-16 13:53 146K 
 KEIsubmissionFrenchC..>2017-11-16 13:46 146K 
 CCIA_Special_301_Com..>2017-11-16 13:24 147K 
 global-patents-poore..>2017-11-16 13:42 147K 
 TPP-2011-Aug-4_Waxma..>2017-11-16 13:54 147K 
 US intervention on H..>2017-11-16 13:54 148K 
 Costco_Supp_Response..>2017-11-16 13:24 148K 
 Joint_Industry_State..>2017-11-16 13:46 149K 
 IIPA-2017-Special-30..>2017-11-16 13:45 149K 
 DOSCable_Brazil_1987..>2017-11-16 13:26 149K 
 2013.4.15IPO_Letter_..>2017-11-16 12:50 150K 
 lovehubbard-code.pdf 2017-11-16 13:49 152K 
 doj_ftc_8jan2013_290..>2017-11-16 13:25 153K 
 publisher_letter_act..>2017-11-16 13:50 153K 
 Mexico_President_2_M..>2017-11-16 13:49 153K 
 Mexico_President_2_K..>2017-11-16 13:49 155K 
 1979_Berne_Conventio..>2017-11-16 12:50 155K 
 07-20-2016-NGO-Lette..>2017-11-16 12:49 156K 
 TPP-2012-May-4_Hutch..>2017-11-16 13:54 156K 
 CEWG_follow_up_meeti..>2017-11-16 13:24 157K 
 KEIcommentonNIHPNAli..>2017-11-16 13:46 157K 
 KEI-USAMRMC-FOIA-San..>2017-11-16 13:46 158K 
 KEI2USPTO-BeijingTre..>2017-11-16 13:46 158K 
 ER_Carlos_Correa_CEI..>2017-11-16 13:42 158K 
 eu-kommission-positi..>2017-11-16 13:42 159K 
 LOEcuadorabacavirLam..>2017-11-16 13:49 159K 
 2015_06_09_14_10_30.pdf2017-11-16 12:50 159K 
 big_prize_fund_overv..>2017-11-16 12:51 159K 
 big_prize_fund_overv..>2017-11-16 12:51 159K 
 ip_2003_11_0.pdf 2017-11-16 13:45 160K 
 Provisionsnotsubject..>2017-11-16 13:50 161K 
 KEI-BN-2015-3-LDC-no..>2017-11-16 13:46 161K 
 32_Reps_Letter_USTR_..>2017-11-16 12:50 161K 
 iipa_special301_2003..>2017-11-16 13:45 162K 
 TPPApunchlist_18may2..>2017-11-16 13:54 162K 
 A67_BCONF2Rev1-en.pdf 2017-11-16 12:50 163K 
 NIH_Report_escitalop..>2017-11-16 13:49 163K 
 15Feb2017HouseMember..>2017-11-16 12:49 163K 
 Struver-CL-History.pdf 2017-11-16 13:53 164K 
 bilski_brief_as_file..>2017-11-16 12:51 164K 
 OvensaInc.pdf 2017-11-16 13:49 165K 
 Chafee_v_FairUse.pdf 2017-11-16 13:24 165K 
 WHO_COI_guidelines_a..>2017-11-17 06:42 166K 
 RCEP-Invesment-Tempo..>2017-11-16 13:53 166K 
 BerneConventionCente..>2017-11-16 12:51 166K 
 damagespatent.pdf 2017-11-16 13:25 167K 
 ER_Aidan_Hollis_Indu..>2023-01-08 08:58 168K 
 Australia_23.11.11_(..>2017-11-16 12:51 168K 
 USproposalPatentsand..>2017-11-16 13:54 168K 
 2017-04-21-US-Army-t..>2017-11-16 12:50 168K 
 s3921_111th_ethical_..>2017-11-16 13:53 169K 
 Goldman-eBay-CLs.pdf 2017-11-16 13:42 169K 
 HIV_AIDS_prize_fund_..>2017-11-16 13:42 169K 
 HIV_AIDS_prize_fund_..>2017-11-16 13:42 169K 
 Public_Citizen_2015_..>2017-11-16 13:50 170K 
 TBC_16may2013_Marrak..>2017-11-16 13:54 170K 
 KITE-NIH-20october20..>2017-11-16 13:46 171K 
 agenda-HHS-PhRMA-etc..>2017-11-16 12:51 172K 
 Shira_Hague_undated.pdf2017-11-16 13:53 172K 
 statement-california..>2017-11-16 13:53 173K 
 JamesLove-KEI-USITC-..>2017-11-16 13:46 173K 
 Bianco-v-Globus-Medi..>2017-11-16 12:51 174K 
 BIO_29feb2013_Colomb..>2017-11-16 12:51 174K 
 ustr_special301_2009..>2017-11-16 13:54 175K 
 SenateBill-as-introd..>2017-11-16 13:53 175K 
 hb0666f.pdf 2017-11-16 13:42 175K 
 kei_rn2011-1_cancer_..>2017-11-16 13:46 175K 
 KEIamicus_AMPvMyriad..>2017-11-16 13:46 176K 
 comparison_tvi_propo..>2017-11-16 13:24 177K 
 prizes_new_medicines..>2017-11-16 13:50 179K 
 prizes_new_medicines..>2017-11-16 13:50 179K 
 ustr_special301_2007..>2017-11-16 13:54 179K 
 KEI-Kite-NIH-Questio..>2017-11-16 13:46 180K 
 ustr_special301_2008..>2017-11-16 13:54 180K 
 AFTI_-_Special_301_-..>2017-11-16 12:51 180K 
 31Aug2015-orphan-wor..>2017-11-16 12:50 181K 
 RCEP_WGIP_JP_Revised..>2017-11-16 13:53 181K 
 TPPA_WaysMeans_Heari..>2017-11-16 13:54 182K 
 A-HRC-12-WG2-TF-CRP4..>2017-11-16 12:50 182K 
 Survey_35944026.pdf 2017-11-16 13:53 182K 
 Section-C-Trademarks..>2017-11-16 13:53 184K 
 TPP-2011-Dec-1_Sande..>2017-11-16 13:54 184K 
 Records_of_the_Confe..>2017-11-16 13:53 185K 
 CAR-T_Kaltenboeck.pdf 2017-11-16 13:24 185K 
 TPP_Copyright_KEI2We..>2017-11-16 13:54 185K 
 NIHCB1comments.pdf 2017-11-16 13:49 186K 
 Amicus_NationalWomen..>2017-11-16 12:51 187K 
 DamagesTPPvUSlawandU..>2017-11-16 13:25 187K 
 comparison_tvi_propo..>2017-11-16 13:24 188K 
 iipa_special301_2007..>2017-11-16 13:45 189K 
 USTR-Request-for-EO1..>2017-11-16 13:54 190K 
 Letter-to-HHS-NIH-re..>2017-11-16 13:49 190K 
 KEI-Special301March4..>2017-11-16 13:46 190K 
 KEI-UACT-April_19_20..>2017-11-16 13:46 190K 
 ustr_special301_2006..>2017-11-16 13:54 190K 
 Department-of-Commer..>2017-11-16 13:25 191K 
 Claire_Cassedy_KEI_C..>2017-11-16 13:24 191K 
 Mylan-GPHA-July 14-T..>2017-11-16 13:49 191K 
 2004_Jan29_ritonavir..>2017-11-16 12:50 191K 
 TPP-2012-July-12_Mur..>2017-11-16 13:54 191K 
 WHOglobalhealthgover..>2017-11-17 06:42 192K 
 5-27-2016-civil-soci..>2017-11-16 12:50 192K 
 DOSCable_Brazil_1987..>2017-11-16 13:25 194K 
 KEI-Goldman-HB666-tr..>2017-11-16 13:46 195K 
 ustr_special301_2001..>2017-11-16 13:54 195K 
 GE-Precious-23May201..>2017-11-16 13:42 195K 
 Replylca-eff-ia-cosl..>2017-11-16 13:53 196K 
 DOSCable_Brazil_1987..>2017-11-16 13:26 199K 
 KEI-miRecule-NIH-18A..>2017-11-16 13:46 201K 
 CorreaDoha+10.ppt 2017-11-16 13:24 204K 
 bcs_ds_bcwf_cat_v4b.pdf2017-11-16 12:51 205K 
 Amicus_AMA_AMPvUSPTO..>2017-11-16 12:51 205K 
 UACT-Special301-OCR-..>2017-11-16 13:54 205K 
 rnib_reply.doc 2017-11-16 13:53 208K 
 EvolutionofReasonabl..>2017-11-16 13:42 208K 
 NPA Support for the ..>2017-11-16 13:49 208K 
 15nov2010-acta.pdf 2017-11-16 12:49 210K 
 acta_15nov2010.pdf 2017-11-16 12:51 210K 
 Draft_4_MatrixofExpo..>2017-11-16 13:26 210K 
 noel_wipo_unesco_85_..>2017-11-16 13:49 211K 
 KEI_FTC_MountSinai_E..>2017-11-16 13:46 211K 
 PWC_school_interent_..>2017-11-16 13:50 212K 
 KEI-TPP-Briefing-201..>2017-11-16 13:46 212K 
 KEI-letter-Zinbryta-..>2017-11-16 13:46 212K 
 Zoltek_CAFC_2009-513..>2017-11-17 06:42 213K 
 BoronNeutronBeijingL..>2017-11-16 12:51 214K 
 ER_Oxford_PIL_Essent..>2017-11-16 13:42 214K 
 testimony_JamesLove_..>2017-11-16 13:54 215K 
 LettertoWIPOHighLeve..>2017-11-16 13:49 215K 
 Love-delinkage_prize..>2017-11-16 13:49 215K 
 acta_aug25_dc.pdf 2017-11-16 12:51 215K 
 2008_wicell_mou_N_02..>2017-11-16 12:50 216K 
 uspto_9mar2010_10-00..>2017-11-16 13:54 216K 
 Zika-Army-21Dec2016.pdf2017-11-17 06:42 217K 
 ustr_special301_2005..>2017-11-16 13:54 218K 
 SECFilings-16March20..>2017-11-16 13:53 219K 
 SECFilings.pdf 2017-11-16 13:53 220K 
 To-Senator-Hatch-Re-..>2017-11-16 13:54 220K 
 iipa_special301_2002..>2017-11-16 13:45 220K 
 KEI_TPP_USTR_Survey_..>2017-11-16 13:46 221K 
 DoS_Brazil_1987mar26..>2017-11-16 13:25 222K 
 KEI_30Jan2015_Commen..>2017-11-16 13:46 222K 
 ustr_special301_2003..>2017-11-16 13:54 222K 
 GILD_Sof_License_Agm..>2017-11-16 13:42 224K 
 KEI-March_10_2017-3r..>2017-11-16 13:46 224K 
 acta1105_en.pdf 2017-11-16 12:51 226K 
 James_Love_KEI_Speci..>2017-11-16 13:46 228K 
 iipa_special301_2009..>2017-11-16 13:45 229K 
 iipa_special301_2004..>2017-11-16 13:45 230K 
 Resolución 2475 de..>2017-11-16 13:53 230K 
 colombia-ministerio-..>2017-11-16 13:24 230K 
 PfizerEuroPatientGro..>2017-11-16 13:49 231K 
 Subsidize-trials-UN-..>2017-11-16 13:53 232K 
 SCCR_23_8_E.pdf 2017-11-16 13:53 233K 
 Manon_Ress_Delinkage..>2017-11-16 13:49 234K 
 DoS_Brazil_1987apr2_..>2017-11-16 13:25 234K 
 Juve.de_.nachrichten..>2017-11-16 13:46 234K 
 Addendum-XV-Internet..>2017-11-16 12:51 234K 
 acta_23april2010_tra..>2017-11-16 12:51 234K 
 2352422-v1-ACTA_Text..>2017-11-16 12:50 235K 
 SanyaDoha+10-14Nov20..>2017-11-16 13:53 235K 
 2010special301ngoSub..>2017-11-16 12:50 237K 
 actaoct2010.pdf 2017-11-16 12:51 238K 
 KEI-comments-sovaldi..>2017-11-16 13:46 238K 
 HolySeeMC9Bali2013.pdf 2017-11-16 13:42 239K 
 KEIstatementtoWHO20t..>2017-11-16 13:46 239K 
 KEI_2014_Special301_..>2017-11-16 13:46 240K 
 iipa_special301_2001..>2017-11-16 13:45 240K 
 ER_Iris_Boutros_Trea..>2017-11-16 13:42 241K 
 IPA SUBMISSION_28 Oc..>2017-11-16 13:45 244K 
 WIPO Summary Report ..>2017-11-17 06:42 245K 
 iipa_special301_2008..>2017-11-16 13:45 245K 
 jol_1998_284_pages1-..>2017-11-16 13:46 245K 
 TPPA_USplus_30Aug201..>2017-11-16 13:54 246K 
 EFF_comments_to_2015..>2017-11-16 13:42 246K 
 UN-HLP-A2M-Transpare..>2017-11-16 13:54 246K 
 GE-Africa-23May2012-..>2017-11-16 13:42 247K 
 WHA MIC Side Event_v..>2017-11-17 06:42 247K 
 GreatLakesNeuroscien..>2017-11-16 13:42 248K 
 HR1776.pdf 2017-11-16 13:42 249K 
 Delinkage_economic-p..>2017-11-16 13:25 250K 
 Multi-Industry-Lette..>2017-11-16 13:49 250K 
 TTIPISDSdamagessecre..>2017-11-16 13:54 250K 
 masthead_bg.png 2017-11-16 13:49 253K 
 PhRMA_industry_profi..>2017-11-16 13:49 254K 
 Press-Release-TPP-Ma..>2017-11-16 13:50 256K 
 TPP-2013-August-8_11..>2017-11-16 13:54 256K 
 Press-Release-TPP-Ma..>2017-11-16 13:50 256K 
 Love-Bayh-Dole.pdf 2017-11-16 13:49 257K 
 CRISPR_Rozen.pdf 2017-11-16 13:24 259K 
 EvolutionofDRMtext_M..>2017-11-16 13:42 259K 
 OECD-17oct2011-exces..>2017-11-16 13:49 259K 
 Swiss-India-EFTA-TEP..>2017-11-16 13:54 260K 
 Abbott-CL-Internatio..>2017-11-16 12:50 260K 
 Xtandi-Press-Release..>2017-11-17 06:42 260K 
 2011Special301Report..>2017-11-16 12:50 261K 
 2011_Special_301_Rep..>2017-11-16 12:50 261K 
 ipab-chennai-order-B..>2017-11-16 13:45 261K 
 Section-A-General-Pr..>2017-11-16 13:53 262K 
 Proyecto-Licencias-O..>2017-11-16 13:50 265K 
 Proyecto Licencias O..>2017-11-16 13:50 265K 
 DOSCable_Brazil_1987..>2017-11-16 13:26 265K 
 DOSCable_Brazil_1987..>2017-11-16 13:26 266K 
 RCEP-Arts19-20 -Serv..>2017-11-16 13:53 266K 
 nz_agenda.pdf 2017-11-16 13:49 266K 
 may-2017-LA-gov-to-a..>2017-11-16 13:49 267K 
 Jamie_Love_End_Produ..>2017-11-16 13:46 268K 
 KEI-MSF-NIH-RSV-comm..>2017-11-16 13:46 268K 
 KEI-MSF-NIH-RSV-comm..>2017-11-16 13:46 268K 
 USproposalpatentshea..>2017-11-16 13:54 270K 
 ICT_Program_2012_FIN..>2017-11-16 13:45 271K 
 PDPFF_concept_note_d..>2017-11-16 13:49 271K 
 NGOletter2Obama-LDC-..>2017-11-16 13:49 272K 
 KEI-2017Special301Re..>2017-11-16 13:46 272K 
 informecomiteimatini..>2017-11-16 13:45 272K 
 informecomiteimatini..>2017-11-16 13:45 272K 
 tpp-10feb2011-us-tex..>2017-11-16 13:54 273K 
 W630.pdf 2017-11-17 06:42 274K 
 TPRIndiaM249A2.doc 2017-11-16 13:54 275K 
 Past-FTAs-text-on-pa..>2017-11-16 13:49 276K 
 KEI-TPP-Briefing-IP-..>2017-11-16 13:46 276K 
 KEI-Briefing-Note-20..>2017-11-16 13:46 277K 
 RonKirk_SFC_9Mar2011..>2017-11-16 13:53 278K 
 TPMs_CommercialAvail..>2017-11-16 13:54 282K 
 SCCR_22_16_Prov_1.doc 2017-11-16 13:53 283K 
 NIHCD70commentsFinal..>2017-11-16 13:49 283K 
 NIH_ChimeronKEIcomme..>2017-11-16 13:49 286K 
 WHABriefforDelegates..>2017-11-17 06:42 286K 
 JuditMSFSCP16.ppt 2017-11-16 13:46 287K 
 JamesLove_Testimony.pdf2017-11-16 13:46 287K 
 DimensionNIHKEIcomme..>2017-11-16 13:25 287K 
 Trastuzumab_Hercepti..>2017-11-16 13:54 288K 
 KEI_Kirtsaeng_brief_..>2017-11-16 13:46 289K 
 KEI_Kirtsaeng_final.pdf2017-11-16 13:46 289K 
 KenyaresolutionR&DCo..>2017-11-16 13:46 290K 
 23july1990_W76.pdf 2017-11-16 12:50 290K 
 Etubics_NIHComments0..>2017-11-16 13:42 292K 
 kei_rn_2010_1.pdf 2017-11-16 13:46 293K 
 Section-D-Geographic..>2017-11-16 13:53 293K 
 12june2013-fda-oda-r..>2017-11-16 12:49 294K 
 Note-on-Zika-vaccine..>2017-11-16 13:49 295K 
 rsc_policy_brief_--_..>2017-11-16 13:53 296K 
 WTO-PublicGoods-UN-H..>2017-11-17 06:42 296K 
 New_Zealand_08.08.11..>2017-11-16 13:49 297K 
 kei-pb-2014-2-Export..>2017-11-16 13:46 297K 
 Replagal_Fabrazyme_T..>2017-11-16 13:53 299K 
 USTRminutesTPR2012M2..>2017-11-16 13:54 299K 
 041712_Comm_Print_KE..>2017-11-16 12:49 301K 
 WIPOexpertTCEtext4in..>2017-11-17 06:42 302K 
 USPTO_Pfizer.pdf 2017-11-16 13:54 302K 
 iipa_special301_2005..>2017-11-16 13:45 302K 
 Amicus_IntellectualP..>2017-11-16 12:51 303K 
 IntelliPanel_NIHKEIc..>2017-11-16 13:45 303K 
 2012Special301Report..>2017-11-16 12:50 304K 
 Harkin-Sanders Lette..>2017-11-16 13:42 305K 
 KEI-Written-Testimon..>2017-11-16 13:46 305K 
 UN-HLP-A2M-RnD-Agree..>2017-11-16 13:54 305K 
 Trastuzumab2_8_2_A_A..>2017-11-16 13:54 307K 
 KEI_6Feb2015_USTR_Sp..>2017-11-16 13:46 308K 
 KEI_USTR_Special_301..>2017-11-16 13:46 308K 
 NIHAquaporinKEI16041..>2017-11-16 13:49 308K 
 Abbvie-EPO-EP680-10N..>2017-11-16 12:50 309K 
 Abbvie-EPO-EP677-10N..>2017-11-16 12:50 310K 
 NIH_report_memantine..>2017-11-16 13:49 310K 
 KEI-USITC-TPP-29Dec2..>2017-11-16 13:46 310K 
 Education_Research_T..>2017-11-16 13:42 310K 
 KEIamicus_Ninestar_v..>2017-11-16 13:46 311K 
 JOncolPharmPract-201..>2017-11-16 13:46 311K 
 KEI-submission-Feb-1..>2017-11-16 13:46 312K 
 SCCR_24_9_Prov.E.doc 2017-11-16 13:53 312K 
 2015_UACT_USTR_Speci..>2017-11-16 12:50 312K 
 ustr_special301_1989..>2017-11-16 13:54 312K 
 Amicus_APILA_AMPvUSP..>2017-11-16 12:51 313K 
 sponsors6_7th_IP_Sym..>2017-11-16 13:53 314K 
 KEI2EmilyBleimund-TP..>2017-11-16 13:46 314K 
 KEI-17USC-1201-Docke..>2017-11-16 13:46 316K 
 olanzapine_zyprexa.xls 2017-11-16 13:49 316K 
 ustr-301-2010.pdf 2017-11-16 13:54 317K 
 ustr_special301_2010..>2017-11-16 13:54 317K 
 2017-Drug-R&D-Transp..>2017-11-16 12:50 317K 
 TPP-2011-September-1..>2017-11-16 13:54 317K 
 SenBrown-WTO-LDC.pdf 2017-11-16 13:53 318K 
 18Jan2017-OIG-Invest..>2017-11-16 12:50 319K 
 12Jan2012-NAM-NFTC-E..>2017-11-16 12:49 320K 
 KEI_Grootendorst_Apr..>2017-11-16 13:46 323K 
 iipa_special301_2006..>2017-11-16 13:45 324K 
 SCCR_24_9_Prov.E.pdf 2017-11-16 13:53 325K 
 Love_Hubbard_Big_Ide..>2017-11-16 13:49 325K 
 CorreaSCP16.ppt 2017-11-16 13:24 326K 
 Annex2CrossReference..>2017-11-16 12:51 329K 
 KEIamicus_FTCvWatson..>2017-11-16 13:46 330K 
 KEIamicus_Bowman_v_M..>2017-11-16 13:46 330K 
 publisher_joint_post..>2017-11-16 13:50 332K 
 CompreviewEWGDec09.doc 2017-11-16 13:24 335K 
 AB 463 support lette..>2017-11-16 12:50 336K 
 Section-G-Copyright-..>2017-11-16 13:53 341K 
 WARFvApple-3-14-cv-0..>2017-11-17 06:42 341K 
 Working_document_VIP..>2017-11-17 06:42 341K 
 sccr_24_10.doc 2017-11-16 13:53 344K 
 KEI-TPP-BriefingNote..>2017-11-16 13:46 346K 
 Email with Attachmen..>2017-11-16 13:42 346K 
 LeMondeOMSPaulHerrli..>2017-11-16 13:49 348K 
 InRe_KDurAntitrustLi..>2017-11-16 13:45 348K 
 KEIcomments_TTIP_9Ma..>2017-11-16 13:46 348K 
 PL96-517.pdf 2017-11-16 13:50 349K 
 Evaluation_Excessive..>2017-11-16 13:42 350K 
 Final-Response-Goldm..>2017-11-16 13:42 350K 
 BiolysePharma-letter..>2017-11-16 12:51 353K 
 2012_Oct25_Ritionavi..>2017-11-16 12:50 357K 
 mtn.gng_.ng11.w.30_3..>2017-11-16 13:49 358K 
 Froman2013Calendars_..>2017-11-16 13:42 358K 
 Froman2013Calendars_..>2017-11-16 13:42 358K 
 NIH_HCV_patent_KEI_P..>2017-11-16 13:49 358K 
 COL196_EN_3.pdf 2017-11-16 13:24 359K 
 NIH_Lentigen_KEIcomm..>2017-11-16 13:49 360K 
 hatch_tpp.pdf 2017-11-16 13:42 361K 
 hatch_tpp_0.pdf 2017-11-16 13:42 361K 
 2016-quarter-1-xtand..>2017-11-16 12:50 363K 
 Non-voluntary_use_HC..>2017-11-16 13:49 367K 
 04-04-2017-House-Let..>2017-11-16 12:49 368K 
 Joe_Larsen_BARDA_Mar..>2017-11-16 13:46 369K 
 msf_comments_to_fr_n..>2017-11-16 13:49 370K 
 msf_comments_to_fr_n..>2017-11-16 13:49 370K 
 lone_holdout.pdf 2017-11-16 13:49 370K 
 cdip_6_6_RevBBBS.doc 2017-11-16 13:24 371K 
 TPP-BriefingNote-201..>2017-11-16 13:54 373K 
 recs-sccr30.pdf 2017-11-16 13:53 375K 
 hwm_05_14_07.pdf 2017-11-16 13:42 375K 
 DeGucht-Piebalgs-EU-..>2017-11-16 13:25 378K 
 ustr_special301_1993..>2017-11-16 13:54 382K 
 PHRMA_Industry_Profi..>2017-11-16 13:49 383K 
 Column_FD9January201..>2017-11-16 13:24 387K 
 UACT-Froman-Oct29201..>2017-11-16 13:54 389K 
 NAFTA-Modernization-..>2017-11-16 13:49 391K 
 OpenSourceCancerDiag..>2017-11-16 13:49 392K 
 UNITAID_ZAIDI_IP_fin..>2017-11-16 13:54 393K 
 ER_James_Love_RND_Co..>2017-11-16 13:42 395K 
 IPO_Special_301_Comm..>2017-11-16 13:46 395K 
 Gilead_CII_Pres-Swam..>2017-11-16 13:42 396K 
 EB140conferencepaper..>2017-11-16 13:42 403K 
 LeMondecoverJanuary2..>2017-11-16 13:49 407K 
 Doggett-51member-Mar..>2017-11-16 13:25 409K 
 KEI-TPP-Copyright-22..>2017-11-16 13:46 410K 
 fabrazyme_petition_2..>2017-11-16 13:42 413K 
 prize-competition-ru..>2017-11-16 13:50 414K 
 IPO_Special_301_Subm..>2017-11-16 13:46 415K 
 CRISPR_Neuman.pdf 2017-11-16 13:24 417K 
 cancer_by_who_region..>2017-11-16 13:24 423K 
 Harkin2ObamaWIPO_TVI..>2017-11-16 13:42 425K 
 gemcitabine_gemzar .xls2017-11-16 13:42 425K 
 Myriad_WOC_KEIbrief_..>2017-11-16 13:49 426K 
 Amicus_YaleISP_AMPvU..>2017-11-16 12:51 426K 
 ER_James_Love_Compen..>2017-11-16 13:42 426K 
 Annex-AntibioticRD.pdf 2017-11-16 12:51 436K 
 WHO_definitions_Type..>2017-11-17 06:42 442K 
 PhRMA_compensation_2..>2017-11-16 13:49 444K 
 Annex_B_European_Uni..>2017-11-16 12:51 452K 
 2015-Special-301-Rep..>2017-11-16 12:50 459K 
 letter-chile-compuls..>2017-11-16 13:49 459K 
 senator_sanders_brow..>2017-11-16 13:53 460K 
 PL-86-726-STATUTE-74..>2017-11-16 13:50 462K 
 DoS_Brazil_18jul1986..>2017-11-16 13:25 465K 
 r2h_anand_grover_tpp..>2017-11-16 13:53 467K 
 kei_wto_agreement_on..>2017-11-16 13:46 470K 
 RedactedPAemails.pdf 2017-11-16 13:53 470K 
 Mylan2Froman-TPP-13A..>2017-11-16 13:49 472K 
 sanders_brown_acta.pdf 2017-11-16 13:53 472K 
 III. Stakeholder Pre..>2017-11-16 13:45 473K 
 TPP_IP_Enforcement_4..>2017-11-16 13:54 474K 
 CAR-T_Love.pdf 2017-11-16 13:24 475K 
 B126_6Add1-en.pdf 2017-11-16 12:51 475K 
 DOSCable_Brazil_1987..>2017-11-16 13:26 476K 
 jdgm2013agenda_en.pdf 2017-11-16 13:46 484K 
 Carta-Ministerio-28A..>2017-11-16 13:24 487K 
 Annex_A_US_Compulsor..>2017-11-16 12:51 488K 
 Senate-Letter-to-Arm..>2017-11-16 13:53 489K 
 RCEP-Competition.pdf 2017-11-16 13:53 490K 
 India_Project_IP_Sum..>2017-11-16 13:45 490K 
 sanders2va-HCV-drugs..>2017-11-16 13:53 501K 
 DoS_Brazil_13nov1987..>2017-11-16 13:25 502K 
 DoS_Brazil_28sep1987..>2017-11-16 13:25 504K 
 Summary_of_comments_..>2017-11-16 13:53 505K 
 sovaldi-lawsuit.pdf 2017-11-16 13:53 512K 
 ewg-comparative-anal..>2017-11-16 13:42 513K 
 mmoran__analysis_fin..>2017-11-16 13:49 513K 
 Mexico_Answer_to_KEI..>2017-11-16 13:49 518K 
 TPP-2011-July-27_40_..>2017-11-16 13:54 520K 
 DOSCable_Brazil_1987..>2017-11-16 13:26 520K 
 Black-Fabrazyme.pdf 2017-11-16 12:51 524K 
 10-1406.pdf 2017-11-16 12:49 528K 
 Froman2016CalendarsR..>2017-11-16 13:42 528K 
 Froman2016Calendars_..>2017-11-16 13:42 528K 
 NIH-MPPF-Patent-Lice..>2017-11-16 13:49 529K 
 Senate-Colombian-Com..>2017-11-16 13:53 530K 
 Senate-Letter-to-San..>2017-11-16 13:53 531K 
 francis_collins_reje..>2017-11-16 13:42 531K 
 canada_c32.pdf 2017-11-16 13:24 533K 
 KEI_UAEM_AMPvUSPTO_a..>2017-11-16 13:46 535K 
 KEI_UAEM_AMPvUSPTO_a..>2017-11-16 13:46 535K 
 gilead-v-abbott.pdf 2017-11-16 13:42 541K 
 sanders-army-zika-10..>2017-11-16 13:53 542K 
 PTKChapter6.pdf 2017-11-16 13:50 542K 
 Amicus_ProteinScienc..>2017-11-16 12:51 545K 
 PhRMA2009_ProfileFIN..>2017-11-16 13:49 546K 
 AnnotatedChecklist.pdf 2017-11-16 12:51 552K 
 Novartis_lawyer_3d.ppt 2017-11-16 13:49 559K 
 DOSCable_Brazil_1987..>2017-11-16 13:26 569K 
 Kesselheim-March-In.pdf2017-11-16 13:46 570K 
 05_01_2013_Special30..>2017-11-16 12:49 572K 
 140886790-Redacted-U..>2017-11-16 12:50 574K 
 david_manon_wipo.pdf 2017-11-16 13:25 580K 
 CRISPR-SecPrice-6Jan..>2017-11-16 13:24 582K 
 5-16-2016-letter-to-..>2017-11-16 12:50 583K 
 kei_rn_2010-5.pdf 2017-11-16 13:46 588K 
 sun-project-peter.pdf 2017-11-16 13:53 598K 
 KEI_USITC_IVN_332-54..>2017-11-16 13:46 601K 
 Section-H-1-11-of-En..>2017-11-16 13:53 603K 
 rds_eb103.4_25nov199..>2017-11-16 13:53 604K 
 CRISPR_Singhroy 2017..>2017-11-16 13:25 609K 
 Section-E-PatentsUnd..>2017-11-16 13:53 623K 
 KEI_MSF_NIH_Zika_Vac..>2017-11-16 13:46 624K 
 PhRMASpecial301Submi..>2017-11-16 13:50 630K 
 phrma_special301_200..>2017-11-16 13:50 630K 
 Sen_Sanders_letter_t..>2017-11-16 13:53 630K 
 PL99-502.pdf 2017-11-16 13:50 630K 
 KEI-CEWG-EURO-antibi..>2017-11-16 13:46 632K 
 PhRMASpecial301Submi..>2017-11-16 13:50 633K 
 Wikileaks-Aug2013-TP..>2017-11-17 06:42 634K 
 Wikileaks-secret-TPP..>2017-11-17 06:42 634K 
 WHOTCM2005.1_OMS.pdf 2017-11-17 06:42 635K 
 jameslove-barcelona.pdf2017-11-16 13:46 638K 
 issues_paper-jdgm201..>2017-11-16 13:46 641K 
 MSF-appeal-dod-zika-..>2017-11-16 13:49 642K 
 SaanapresentationTRI..>2017-11-16 13:53 645K 
 Norvir_NIH_Signed_De..>2017-11-16 13:49 649K 
 FOIA_Thailand_CLs_pa..>2017-11-16 13:42 652K 
 who_undp_2005_royalt..>2017-11-17 06:42 655K 
 nyt-frontpage-20dec2..>2017-11-16 13:49 655K 
 draft_decision_aroun..>2017-11-16 13:26 674K 
 Wyden_Letter_to_USTR..>2017-11-17 06:42 678K 
 Amicus_Gatschet_AMPv..>2017-11-16 12:51 687K 
 Edited20121212_09111..>2017-11-16 13:42 688K 
 confurep.pdf 2017-11-16 13:24 688K 
 PhRMA_USTR-2010-0003..>2017-11-16 13:50 691K 
 USTR-2010-0003-0245...>2017-11-16 13:54 691K 
 congressional-letter..>2017-11-16 13:24 699K 
 steward_baker_schwab..>2017-11-16 13:53 700K 
 HHS_Penn_CART_patent..>2017-11-16 13:42 706K 
 kei-sampat-nov-10.pdf 2017-11-16 13:46 716K 
 phrma_special301_200..>2017-11-16 13:50 720K 
 tpp-ip2-chapter-16Ma..>2017-11-16 13:54 720K 
 phrma_special301_200..>2017-11-16 13:50 724K 
 Florez-27April2016.pdf 2017-11-16 13:42 724K 
 DoS_Brazil_26mar1986..>2017-11-16 13:25 725K 
 stand_mccoy_transpar..>2017-11-16 13:53 728K 
 Tufts_CSDD_briefing_..>2017-11-16 13:54 729K 
 USTR_2014_Special301..>2017-11-16 13:54 755K 
 Novartis_v_UoI-judge..>2017-11-16 13:49 758K 
 mtn.tnc_.6_17aug1988..>2017-11-16 13:49 765K 
 Xtandi-March-In-Requ..>2017-11-17 06:42 770K 
 AssessingTRIPS Imple..>2017-11-16 12:51 772K 
 KEI_PaxVax.pdf 2017-11-16 13:46 772K 
 USPTO-Pfizer_Tie_up_..>2017-11-16 13:54 780K 
 FL Letter to Army re..>2017-11-16 13:42 782K 
 WikiLeaks-TPP-Invest..>2017-11-17 06:42 784K 
 TRIPS on flexibiliti..>2017-11-16 13:54 802K 
 PhRMA_2002_p02_07_ap..>2017-11-16 13:49 803K 
 House-Dem-LDC-Letter..>2017-11-16 13:42 806K 
 Biden_Colombia_8sep2..>2017-11-16 12:51 809K 
 transparency-legisla..>2017-11-16 13:54 814K 
 greece_a2m_meeting_3..>2017-11-16 13:42 819K 
 chapter2.pdf 2017-11-16 13:24 827K 
 irff_page68.pdf 2017-11-16 13:46 829K 
 WIPOSCCR26Conclusion..>2017-11-17 06:42 836K 
 BIO-2017-Special-301..>2017-11-16 12:51 841K 
 Froman2014Calendars_..>2017-11-16 13:42 849K 
 Froman2014Calendars_..>2017-11-16 13:42 849K 
 Sanders_USTR_letter_..>2017-11-16 13:53 869K 
 20100126.wipo_.stand..>2017-11-16 12:50 876K 
 ncd-6healthngos-mosc..>2017-11-16 13:49 887K 
 merck-email.pdf 2017-11-16 13:49 895K 
 Evaluation_Essential..>2017-11-16 13:42 921K 
 Ress_BrazilVIISEMINA..>2017-11-16 13:53 934K 
 Glivec-Carta-OMS-25M..>2017-11-16 13:42 944K 
 WIPOSCCR26Conclusion..>2017-11-17 06:42 944K 
 2015_BIO_Submission.pdf2017-11-16 12:50 945K 
 DOSCable_Brazil_1987..>2017-11-16 13:26 955K 
 ustr_special301_1990..>2017-11-16 13:54 962K 
 bernegap.pdf 2017-11-16 12:51 965K 
 2017Special301Report..>2017-11-16 12:50 1.0M 
 Holleyman_calendar_R..>2017-11-16 13:42 1.0M 
 Holleyman_calendar_R..>2017-11-16 13:42 1.0M 
 WIPOSCCRConclusionsP..>2017-11-17 06:42 1.0M 
 WIPOSCCR26Conclusion..>2017-11-17 06:42 1.0M 
 Tim_Hubbard_Intermed..>2017-11-16 13:54 1.0M 
 1965_quotation_right..>2017-11-16 12:50 1.0M 
 ip_intensive_industr..>2017-11-16 13:46 1.0M 
 ADG - 10 March 2011 ..>2017-11-16 12:51 1.0M 
 StockholmConferenceR..>2017-11-16 13:53 1.0M 
 ustr_special301_1995..>2017-11-16 13:54 1.0M 
 wipo_cdip_14_inf_12_..>2017-11-17 06:42 1.0M 
 ustr_special301_1994..>2017-11-16 13:54 1.1M 
 Questions-Answers-Li..>2017-11-16 13:53 1.1M 
 Froman2015Calendars_..>2017-11-16 13:42 1.1M 
 Froman2015Calendars_..>2017-11-16 13:42 1.1M 
 DoS_Brazil_3Apr1986_..>2017-11-16 13:26 1.1M 
 national-ipr-policy.pdf2017-11-16 13:49 1.1M 
 PhRMA-2017-Special-3..>2017-11-16 13:49 1.1M 
 DoS_Brazil_1986jul2_..>2017-11-16 13:25 1.1M 
 ustr_acta_response.pdf 2017-11-16 13:54 1.1M 
 mandelson07102007.pdf 2017-11-16 13:49 1.1M 
 CEWG_Report_5_April_..>2017-11-16 13:24 1.1M 
 RCEP AIDS Access 24...>2017-11-16 13:53 1.1M 
 sccrcasting.pdf 2017-11-16 13:53 1.2M 
 ustr_special301_1991..>2017-11-16 13:54 1.2M 
 CRISPR_Contreras.pdf 2017-11-16 13:25 1.2M 
 Aidan_Hollis_Antibio..>2017-11-16 12:51 1.2M 
 PMAC TPP presentatio..>2017-11-16 13:50 1.2M 
 patent-of-Imatinib-g..>2017-11-16 13:49 1.2M 
 PhRMA_Special301_21f..>2017-11-16 13:50 1.2M 
 ustr_special301_1996..>2017-11-16 13:54 1.2M 
 Patent Pool Oct 2011..>2017-11-16 13:49 1.3M 
 PhRMA_Profile_2010_F..>2017-11-16 13:50 1.3M 
 24July2015-11-pro-tp..>2017-11-16 12:50 1.3M 
 tunis_OCR model_law_..>2017-11-16 13:54 1.3M 
 CAR-T_Mitchell.pdf 2017-11-16 13:24 1.3M 
 TPRIndiaSeptember201..>2017-11-16 13:54 1.3M 
 draft_ewg_report_20n..>2017-11-16 13:26 1.3M 
 ewg-report-draft-20-..>2017-11-16 13:42 1.3M 
 mtn.gng_.ng11.w.70_1..>2017-11-16 13:49 1.3M 
 DoS_Brazil_25jul1986..>2017-11-16 13:25 1.3M 
 CARMEN PEREZ_2011GF_..>2017-11-16 13:24 1.4M 
 1965_General_report_..>2017-11-16 12:50 1.4M 
 phrma_profile_2011_f..>2017-11-16 13:50 1.4M 
 PL-98-551-STATUTE-98..>2017-11-16 13:50 1.4M 
 CAR-T_Singhroy.pdf 2017-11-16 13:24 1.4M 
 DoS_Brazil_10mar1986..>2017-11-16 13:25 1.4M 
 CEWG_Report_5_April_..>2017-11-16 13:24 1.4M 
 mtn.gng_.ng11.w.68_2..>2017-11-16 13:49 1.4M 
 pdpff27feb09.doc 2017-11-16 13:49 1.4M 
 USTPRDecember2012roo..>2017-11-16 13:54 1.4M 
 kirk_response_ldc._i..>2017-11-16 13:46 1.5M 
 Joint Communications..>2017-11-16 13:46 1.5M 
 StockholmConferenceR..>2017-11-16 13:53 1.5M 
 1967stockholmprotoco..>2017-11-16 12:50 1.5M 
 PhRMA_2015_Special_3..>2017-11-16 13:49 1.6M 
 ustr-oct9letter_foia..>2017-11-16 13:54 1.6M 
 Doha+10.ppt 2017-11-16 13:25 1.6M 
 Rachel_Cohen_DNDi_Mo..>2017-11-16 13:53 1.6M 
 Tunis_model_law_copy..>2017-11-16 13:54 1.6M 
 tunis_model_law_en-w..>2017-11-16 13:54 1.6M 
 IP_Report_March_2012..>2017-11-16 13:46 1.6M 
 Communities and IP.ppt 2017-11-16 13:24 1.7M 
 sccr28.pdf 2017-11-16 13:53 1.7M 
 Amicus_ABA_AMPvUSPTO..>2017-11-16 12:51 1.7M 
 WTO-Lamy_Answer-to-M..>2017-11-17 06:42 1.7M 
 jorge bermudez 1 Gen..>2017-11-16 13:46 1.7M 
 wanda_noel_1985.pdf 2017-11-17 06:42 1.7M 
 CRISPR_Sherkow.pdf 2017-11-16 13:25 1.8M 
 ambkirk_may2_sept09.pdf2017-11-16 12:51 1.8M 
 Diane_Singhroy_Open_..>2017-11-16 13:25 1.9M 
 sccr30-summary-chair..>2017-11-16 13:53 1.9M 
 RedactedACTACRSMemot..>2017-11-16 13:53 1.9M 
 FOIA_Thailand_CLs_pa..>2017-11-16 13:42 1.9M 
 Francis Collins resp..>2017-11-16 13:42 1.9M 
 SoS_Brazil_27May1986..>2017-11-16 13:53 1.9M 
 FOIA_Thailand_CLs_pa..>2017-11-16 13:42 1.9M 
 2016Fund6 pager.pdf 2017-11-16 12:50 2.0M 
 ACTA-6437-10.pdf 2017-11-16 12:51 2.0M 
 eu_12feb2010_ACTA-64..>2017-11-16 13:42 2.0M 
 banff-p2p-cl.pdf 2017-11-16 12:51 2.0M 
 HatchClintonGlobalFu..>2017-11-16 13:42 2.0M 
 Baker - MPP.ppt 2017-11-16 12:51 2.0M 
 modelprovisions-comp..>2017-11-16 13:49 2.0M 
 Obama-TPP-will-raise..>2017-11-16 13:49 2.0M 
 sorafenib_nexavar_co..>2017-11-16 13:53 2.1M 
 pl_98-620.pdf 2017-11-16 13:50 2.1M 
 donnashalala2janscha..>2017-11-16 13:25 2.1M 
 d3-1815.pdf 2017-11-16 13:25 2.2M 
 IIHI_Oncology_Trend_..>2017-11-16 13:45 2.2M 
 06-18-13-House-India..>2017-11-16 12:50 2.2M 
 ustr_special301_1992..>2017-11-16 13:54 2.2M 
 WIPO-Dipl_OCR-Conf-D..>2017-11-17 06:42 2.2M 
 PhRMA_2014_Special_3..>2017-11-16 13:49 2.3M 
 USTR-2016-Special-30..>2017-11-16 13:54 2.3M 
 Kite-NIH-2012-CRADA-..>2017-11-16 13:46 2.3M 
 UNSG_HLP_A2M_Report_..>2017-11-16 13:54 2.3M 
 Punke Calendar_Jan20..>2017-11-16 13:50 2.3M 
 Punke Calendar_Jan20..>2017-11-16 13:50 2.3M 
 IP-WATCH-Final-Relea..>2017-11-16 13:46 2.3M 
 Wyden-Grassley_Gilea..>2017-11-17 06:42 2.3M 
 Fabrazyme-NIH-Sinai_..>2017-11-16 13:42 2.3M 
 JointNGOStatementLDC..>2017-11-16 13:46 2.4M 
 Kite-NIH-01-2016-CRA..>2017-11-16 13:46 2.4M 
 PhRMA_990_2008.pdf 2017-11-16 13:50 2.4M 
 Outterson Chatham Ho..>2017-11-16 13:49 2.4M 
 FOIA-GE-Treaty-for-B..>2017-11-16 13:42 2.4M 
 Hollis-KEI-Aug2015.pdf 2017-11-16 13:42 2.5M 
 DoS_Brazil_16oct1986..>2017-11-16 13:25 2.6M 
 mtn.gng_.ng11.13_16a..>2017-11-16 13:49 2.6M 
 IIPA-2017-Special-30..>2017-11-16 13:45 2.8M 
 DoS_Brazil_25july198..>2017-11-16 13:26 2.8M 
 PL97-414-STATUTE-96-..>2017-11-16 13:50 2.9M 
 Katy_Athersuch_3P_TB..>2017-11-16 13:46 2.9M 
 1965_general_report_..>2017-11-16 12:50 2.9M 
 records_1967stockhol..>2017-11-16 13:53 3.0M 
 Compulsory LicenseRe..>2017-11-16 13:25 3.0M 
 compulsory-201011.pdf 2017-11-16 13:25 3.0M 
 jamie_13may2010_DSC_..>2017-11-16 13:46 3.1M 
 OECD-Excessive_Price..>2017-11-16 13:49 3.1M 
 2015_Special_301_Sub..>2017-11-16 12:50 3.2M 
 phrma_industry_profi..>2017-11-16 13:50 3.2M 
 Tax-Expenditures-FY2..>2017-11-16 13:54 3.2M 
 StockholmConferenceR..>2017-11-16 13:54 3.4M 
 PAE-proposal-RSA-pat..>2017-11-16 13:49 3.5M 
 DoS_Brazil_7nov1986_..>2017-11-16 13:26 3.6M 
 orphan-works-CO-2015..>2017-11-16 13:49 3.6M 
 Jamie_21March-2016-I..>2017-11-16 13:46 3.6M 
 iipa_USTR-2010-0003-..>2017-11-16 13:46 3.7M 
 Amicus_Gilead_AMPvUS..>2017-11-16 12:51 3.8M 
 2012-FOIA-USTR-CEWG-..>2017-11-16 12:50 3.8M 
 Ellen_t_Hoen_Lancet_..>2017-11-16 13:42 3.9M 
 thailand_03Mar2009_S..>2017-11-16 13:54 4.1M 
 Model_law_patents_vo..>2017-11-16 13:49 4.2M 
 sccr26.pdf 2017-11-16 13:53 4.2M 
 DoS_Brazil_19nov1986..>2017-11-16 13:26 4.4M 
 ParisConference1971-..>2017-11-16 13:49 4.5M 
 2013-12-18-D6-REDACT..>2017-11-16 12:51 4.9M 
 ecuador_license_abc_..>2017-11-16 13:42 4.9M 
 PhRMA_ScheduleI_2008..>2017-11-16 13:50 5.0M 
 F-13-00172_Final Res..>2017-11-16 13:42 5.0M 
 iipa_Special301_21fe..>2017-11-16 13:46 5.0M 
 model_law_patents_19..>2017-11-16 13:49 5.7M 
 F-13-00172_OCR_Final..>2017-11-16 13:42 5.7M 
 F-13-00172_OCR_Final..>2017-11-16 13:42 5.7M 
 ParisConference1971-..>2017-11-16 13:49 6.2M 
 thailand_01Mar2011_S..>2017-11-16 13:54 7.0M 
 thailand_01Mar2010_S..>2017-11-16 13:54 7.0M 
 Model_law_patents_vo..>2017-11-16 13:49 7.0M 
 thailand_23Dec2010_S..>2017-11-16 13:54 7.1M